GSK233705/GW642444

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK233705/GW642444, covering 2020-09-01 to 2020-09-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of Repeat Dosing of GSK233705/GW642444 in COPD [Phase 2]